Published in PLoS One on March 12, 2015
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology (2000) 4.97
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Occult hepatitis B. Lancet Infect Dis (2002) 3.09
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology (2001) 2.80
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut (2004) 2.59
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis (1998) 1.69
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61
Clinical impact of occult HBV infections. J Clin Virol (2005) 1.46
Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol (1999) 1.34
Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol (2012) 1.29
Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol (2014) 1.27
Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett (2009) 1.22
Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis (2008) 1.17
Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion (2002) 1.16
Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther (2010) 1.15
Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol (2009) 1.14
Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol (2006) 1.14
The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol (2007) 1.12
Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One (2013) 1.11
Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect (2006) 1.10
Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection (2009) 1.08
Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci (2010) 1.06
Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol (2009) 1.01
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol (2009) 0.97
Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol (2006) 0.96
Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab (2004) 0.95
Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol (2000) 0.93
Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol (2013) 0.87
The clinical significance of occult HBV infection. Ann Gastroenterol (2014) 0.83